Olivier Kitten

Olivier Kitten is the Founder and CEO of Affilogic, a company established in February 2010 that specializes in developing custom affinity ligands for various applications including analytics, bioprocessing, in vitro diagnostics, in vivo imaging, and therapeutic uses. Prior to Affilogic, Olivier held positions as Coordinator at Atlantic Biotherapies from November 2005 to August 2009, Life Sciences Manager at Atlanpole from December 2002 to August 2009, COO at Atlangene Applications from January 2001 to December 2002, and Senior Scientist at Rhone-Poulenc Rorer Gencell from 1997 to 2001. Olivier Kitten completed a Ph.D. in Gene Transfer at Université de Rennes I from 1994 to 1997 and studied at CentraleSupélec from 1991 to 1993.